Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chudzinski-Tavassi
Ana Marisa Chudzinski-Tavassi, Sao Paulo BR
| Patent application number | Description | Published |
|---|---|---|
| 20080267944 | Process for Obtaining Recombinant Prothrombin Activating Protease (Rlopap) in Monomeric form; the Recombinant Prothrombin Activating Protease (Rlopap) as Well as its Amino Acid Sequence; the Use of this Protease as a Defibrinogenase - This invention refers to the process for obtaining the recombinant prothrombin activating protease (rLopap) in monomeric form, the recombinant prothrombin activating protease (rLopap), as well as its amino acid sequence. In addition to that, this invention also refers to the use of this protease for depleting the blood fibrinogen, and serve as diagnosis kit for dysprothrombinemias. This invention describes the obtainence in recombinant form and the characterization of a prothrombin activator protease of 21 kDa, named rLopap ( | 10-30-2008 |
| 20090170182 | LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF - The invention refers to pharmaceutical compositions and cosmetic compositions comprising a prophylactic or therapeutically effective quantity of at least one polypeptide substantially identical to Lopap (a lipocalin-related protein with prothrombin activating protease activity). The invention refers to the use of these compositions as modulators of cell death and anti-aging agents. | 07-02-2009 |
| 20110034390 | PEPTIDES, COMPOSITIONS, AND USES THEREOF - Compositions for regenerating tissue and wound repair, among other applications, are described. | 02-10-2011 |
Ana Marisa Chudzinski-Tavassi, Sao Paulo Sp BR
| Patent application number | Description | Published |
|---|---|---|
| 20090042786 | Kunitz-type recombinant inhibitor - The present invention presents a Kunitz-type recombinant inhibitor obtained from a gene cloned from a cDNA library of salivary glands of the | 02-12-2009 |
Ana Marisa Chudzinski-Tavassi, São Paulo BR
| Patent application number | Description | Published |
|---|---|---|
| 20090170182 | LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF - The invention refers to pharmaceutical compositions and cosmetic compositions comprising a prophylactic or therapeutically effective quantity of at least one polypeptide substantially identical to Lopap (a lipocalin-related protein with prothrombin activating protease activity). The invention refers to the use of these compositions as modulators of cell death and anti-aging agents. | 07-02-2009 |